Lead Product(s) : OLX104C
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference
Details : OliX, will deliver a focused company’s proprietary asymmetric siRNA technology and pipeline programs, including OLX104C for hair loss, OLX301A for wet/dry age-related macular degeneration, OLX702A for non-alcoholic steatohepatitis, and OLX703A for hepa...
Product Name : OLX104C
Product Type : Oligonucleotide
Upfront Cash : Inapplicable
July 02, 2022
Lead Product(s) : OLX104C
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable